1. 1349. Global Surveillance of Cefiderocol Against Gram-Negative Clinical Strains Collected in North America: SIDERO-WT-2015. (26th November 2018) Authors: Tsuji, Masakatsu; Hackel, Meredith; Echols, Roger; Yamano, Yoshinori; Sahm, Dan Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1366. In Vitro and In Vivo Activity of Cefiderocol against Stenotrophomonas maltophilia Clinical Isolates. (26th November 2018) Authors: Ito, Akinobu; Ota, Merime; Nakamura, Rio; Tsuji, Masakatsu; Sato, Takafumi; Yamano, Yoshinori Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2388. Efficacy of Humanized Cefiderocol Exposures Over 72 Hours Against a Diverse Group of Gram-Negative Isolates in the Neutropenic Murine Thigh Infection Model. (26th November 2018) Authors: Stainton, Sean; Monogue, Marguerite; Tsuji, Masakatsu; Yamano, Yoshinori; Echols, Roger; Nicolau, David P Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 248S-649266, a Novel Siderophore Cephalosporin: Efficacy against Klebsiella pneumoniae producing NDM-1 or KPC in rat lung infection model with recreated humanized exposure profile of 2 gram dose with 1 hour and 3 hours infusion. (December 2014) Authors: Tsuji, Masakatsu; Singley, Christine; Horiyama, Tsukasa; Nakamura, Rio; Echols, Roger; Rittenhouse, Stephen; Yamano, Yoshionori; Shimada, Jingoro Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 252S-649266, a Novel Siderophore Cephalosporin: In vitro activity against Gram-negative bacteria. (December 2014) Authors: Tsuji, Masakatsu; Ito, Akinobu; Nakamura, Rio; Yamano, Yoshionori; Shimada, Jingoro Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 256S-649266, a Novel Siderophore Cephalosporin: Mechanisms of enhanced activity and beta-lactamase stability. (December 2014) Authors: Tsuji, Masakatsu; Ito, Akinobu; Horiyama, Tsukasa; Fukuhara, Norio; Nakamura, Rio; Yamano, Yoshionori; Shimada, Jingoro; Ishii, Yoshikazu; Yamaguchi, Keizo; Tateda, Kazuhiro Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 696. Mechanism of Cefiderocol high MIC mutants obtained in non-clinical FoR studies. (26th November 2018) Authors: Ito, Akinobu; Nishikawa, Toru; Ishii, Ryuta; Kuroiwa, Miho; Ishioka, Yoshino; Kurihara, Naoko; Sakikawa, Ikue; Ota, Takeshi; Rokushima, Masatomo; Tsuji, Masakatsu; Sato, Takafumi; Yamano, Yoshinori Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparison of the risk of acquiring in vitro resistance to doripenem and tazobactam/piperacillin by CTX-M-15-producing Escherichia coli. Issue 5 (May 2015) Authors: Horiyama, Tsukasa; Kanazawa, Sachi; Hara, Takafumi; Izawa, Masaaki; Sato, Takafumi; Yamaguchi, Takahiro; Tsuji, Masakatsu; Maki, Hideki Journal: Journal of infection and chemotherapy Issue: Volume 21:Issue 5(2015:May) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Good Correlation of Cefiderocol Between In Vivo Efficacy Murine Thigh/Lung Infection Models and MIC Determined in Iron-Depleted Conditions. (4th October 2017) Authors: Yamano, Yoshinori; Nakamura, Rio; Sato, Takafumi; Tsuji, Masakatsu; Echols, Roger Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan. (23rd October 2018) Authors: Hsueh, Shun-Chung; Lee, Yuarn-Jang; Huang, Yu-Tsung; Liao, Chun-Hsing; Tsuji, Masakatsu; Hsueh, Po-Ren Journal: Journal of antimicrobial chemotherapy Issue: Volume 74:Number 2(2019) Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗